About HIBio
HIBio is a company based in Foshan (China) founded in 2021 by Travis Murdoch was acquired by Biogen in May 2024.. HIBio has raised $215 million across 2 funding rounds from investors including Biogen, Arch Venture Partners and Arkin. HIBio offers products and services including Neurological Therapies. HIBio operates in a competitive market with competitors including Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
- Headquarter Foshan, China
- Founders Travis Murdoch
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HIBio
HIBio offers a comprehensive portfolio of products and services, including Neurological Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for neurological disorders like Alzheimer's
Unlock access to complete
Leadership Team
2 people
Senior Team
2 people
Chair Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of HIBio
HIBio has successfully raised a total of $215M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $95 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $95.0M
-
First Round
First Round
(01 Nov 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series B - HIBio | Valuation | Alpha Wave Global | |
| Nov, 2022 | Amount | Series B - HIBio | Valuation | Arch Venture Partners , Monograph |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HIBio
HIBio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Arch Venture Partners and Arkin. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on growth-stage companies
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Jeito Capital is focused on financing medical innovation globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HIBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HIBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hibio Comparisons
Competitors of HIBio
HIBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hibio
Frequently Asked Questions about HIBio
When was HIBio founded?
HIBio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is HIBio located?
HIBio is headquartered in Foshan, China. It is registered at Foshan, Guangdong, China.
Who is the current CEO of HIBio?
Travis Murdoch is the current CEO of HIBio. They have also founded this company.
Is HIBio a funded company?
HIBio is a funded company, having raised a total of $215M across 2 funding rounds to date. The company's 1st funding round was a Series B of $120M, raised on Nov 01, 2022.
What does HIBio do?
HIBio was founded in 2021 in Foshan, China, by Travis Murdoch, who serves as CEO. Operations focus on the biotechnology sector, where precision medicines targeting autoimmune and inflammatory diseases are developed. Research and development activities are centered in China, with an emphasis on therapeutic innovations for unmet medical needs in immunology. The companys domain, hibio.com, supports its ongoing efforts in this field.
Who are the top competitors of HIBio?
HIBio's top competitors include ADMA Biologics, BioNTech and Generate Biomedicines.
What products or services does HIBio offer?
HIBio offers Neurological Therapies.
Who are HIBio's investors?
HIBio has 7 investors. Key investors include Biogen, Arch Venture Partners, Arkin, Alpha Wave Global, and Viking Global Investors.